1-3 of 3
Authors: Prashni Paliwal
Save search
Sort by
Journal Article

ATIM-19. POPULATION PHARMACOKINETIC (PPK) ANALYSIS OF NIVOLUMAB FLAT AND WEIGHT-BASED DOSING REGIMENS AND ASSOCIATIONS WITH SAFETY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM) TREATED IN CHECKMATE 143 Free

PDF
Jun Shen and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi30, https://doi.org/10.1093/neuonc/nox168.114
Published: 06 November 2017
Journal Article
EDITOR'S CHOICE

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143 Free

PDF
Antonio Omuro and others
Neuro-Oncology, Volume 20, Issue 5, May 2018, Pages 674–686, https://doi.org/10.1093/neuonc/nox208
Published: 28 October 2017
Journal Article

ATIM-16. NIVOLUMAB COMBINED WITH RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS FROM PHASE 1 SAFETY COHORTS IN CHECKMATE 143 Free

PDF
Antonio Omuro and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi21, https://doi.org/10.1093/neuonc/now212.081
Published: 07 November 2016